CRISPR Therapeutics shares traded as high as $200 18 months ago, but today the share price is $62, and market cap valuation $4.75bn. Read about CRSP here.
CRISPR Therapeutics' share price has fallen by half across the past 12 months, but may soon win approval in Sickle Cell Disease. Read more on CRSP stock here.
Researchers have created the largest-ever family tree – a genealogical network of human genetic diversity – that is a major step towards mapping the genetic
Experts from the Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard successfully designed a new type of prime editing that can install or swap out gene-sized DNA sequences. This breakthrough is published in Nature Biotechnology.